open access

Vol 28, No 1 (2021)
Research Letter
Submitted: 2020-04-29
Accepted: 2020-07-21
Published online: 2020-07-29
Get Citation

Familial dilated cardiomyopathy associated with a novel heterozygous RYR2 early truncating variant

Sarah Costa1, Argelia Medeiros-Domingo2, Alessio Gasperetti1, Alexander Breitenstein1, Jan Steffel1, Federica Guidetti1, Andreas Flammer1, Katja Odening3, Frank Ruschitzka1, Firat Duru14, Ardan M. Saguner1
·
Pubmed: 32748945
·
Cardiol J 2021;28(1):173-175.
Affiliations
  1. Department of Cardiology, University Heart Center, Zurich, Switzerland
  2. Swiss Dnalysis, Dubendorf, Switzerland
  3. Department of Cardiology, University Hospital Bern, Bern, Switzerland
  4. Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland

open access

Vol 28, No 1 (2021)
Research letters — Clinical cardiology
Submitted: 2020-04-29
Accepted: 2020-07-21
Published online: 2020-07-29

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Familial dilated cardiomyopathy associated with a novel heterozygous RYR2 early truncating variant

Journal

Cardiology Journal

Issue

Vol 28, No 1 (2021)

Article type

Research Letter

Pages

173-175

Published online

2020-07-29

Page views

1092

Article views/downloads

1118

DOI

10.5603/CJ.a2020.0099

Pubmed

32748945

Bibliographic record

Cardiol J 2021;28(1):173-175.

Authors

Sarah Costa
Argelia Medeiros-Domingo
Alessio Gasperetti
Alexander Breitenstein
Jan Steffel
Federica Guidetti
Andreas Flammer
Katja Odening
Frank Ruschitzka
Firat Duru
Ardan M. Saguner

References (10)
  1. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003; 348(17): 1647–1655.
  2. McKenna WJ, Maron BJ, Thiene G. Classification, epidemiology, and global burden of cardiomyopathies. Circ Res. 2017; 121(7): 722–730.
  3. McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017; 121(7): 731–748.
  4. Cerrone M, Colombi B, Santoro M, et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res. 2005; 96(10): e77–e82.
  5. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405–424.
  6. Ohno S, Omura M, Kawamura M, et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace. 2014; 16(11): 1646–1654.
  7. Meissner G. The structural basis of ryanodine receptor ion channel function. J Gen Physiol. 2017; 149(12): 1065–1089.
  8. Tang Y, Tian X, Wang R, et al. Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies. Circ Res. 2012; 110(7): 968–977.
  9. Ullrich ND, Fanchaouy M, Gusev K, et al. Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes. Am J Physiol Heart Circ Physiol. 2009; 297(6): H1992–H2003.
  10. Bhuiyan ZA, van den Berg MP, van Tintelen JP, et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation. 2007; 116(14): 1569–1576.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl